Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operations:      
Net income $ 220,816 $ 212,182 $ 180,160
Adjustments to reconcile net income to net cash provided by operations:      
Depreciation and amortization of property, plant, equipment and capitalized software 51,884 55,769 58,404
Amortization of intangible assets 10,308 12,208 13,377
Deferred income taxes 6,721 4,762 5,652
Stock compensation expense 20,238 21,365 18,751
Gain on sale of business 0 (650) (6,880)
Changes in assets and liabilities, net of effects of business combinations:      
Accounts receivable—billed and billable 34,033 53,025 (51,986)
Accounts receivable—unbilled 4,920 26 (5,590)
Prepaid expenses and other current assets 4,954 2,584 (2,027)
Deferred contract costs 1,838 2,037 (398)
Accounts payable and accrued liabilities (7,725) (28,309) (2,371)
Accrued compensation and benefits (8,795) 8,849 (869)
Deferred revenue (27,039) (15,401) (11,661)
Income taxes 7,262 8,901 (13,125)
Other assets and liabilities 4,110 (148) (1,411)
Cash provided by operations 323,525 337,200 180,026
Cash flows from investing activities:      
Purchases of property and equipment and capitalized software costs (26,520) (24,154) (46,391)
Acquisition of businesses, net of cash acquired 0 (2,677) (46,651)
Acquisition of part of noncontrolling interest (157) 0 0
Proceeds from the sale of a business 0 1,035 5,515
Purchases of short-term investments (19,996) 0 0
Other 369 575 424
Cash used in investing activities (46,304) (25,221) (87,103)
Cash flows from financing activities:      
Cash dividends paid to MAXIMUS shareholders (11,692) (11,674) (11,701)
Repurchases of common stock (66,919) (28,863) (33,335)
Tax withholding related to RSU vesting (8,529) (9,175) (11,614)
Borrowings under credit facility 136,632 185,000 149,823
Repayment of credit facility and other long-term debt (136,769) (349,981) (195,200)
Stock option exercises 0 924 546
Stock compensation tax benefit 0 0 5,172
Other (4,603) (1,660) (533)
Cash used in financing activities (91,880) (215,429) (96,842)
Effect of exchange rate changes on cash (2,348) 3,503 (4,554)
Net increase/(decrease) in cash and cash equivalents 182,993 100,053 (8,473)
Cash and cash equivalents, beginning of period 166,252 66,199 74,672
Cash and cash equivalents, end of period $ 349,245 $ 166,252 $ 66,199